Logo R150 (Pradaxa 150 mg)
Generic Name: dabigatran
Pill imprint Logo R150 has been identified as Pradaxa 150 mg.
Pradaxa is used in the treatment of prevention of thromboembolism in atrial fibrillation; deep vein thrombosis; pulmonary embolism; deep vein thrombosis/pulmonary embolism prophylaxis following hip replacement surgery; deep vein thrombosis, prophylaxis and belongs to the drug class thrombin inhibitors. Risk cannot be ruled out during pregnancy. Pradaxa 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Logo R150
- 150 mg
- Blue / Beige
- Prescription only
- Drug Class:
- Thrombin inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Boehringer Ingelheim Pharmaceuticals, Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54569-6276||A-S Medication Solutions, LLC (repackager)|
Note: Inactive ingredients may vary.
More about Pradaxa (dabigatran)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.